ACC 2018

ACC 2018 Meeting Highlights

Patent Foramen Ovale Characteristics May Predict Benefits of PFO Closure

By

Nicole Clemons

March 16, 2018

Patent foramen ovale closure resulted in a lower recurrence of stroke in patients with cryptogenic stroke and high-risk PFO characteristics.

ACC 2018 Meeting Highlights

Low-Dose Triple Combo Therapy Effective in Hypertension

March 16, 2018

A low-dose triple combination therapy was found to be effective in achieving rapid blood pressure control in patients with hypertension.

ACC 2018 Meeting Highlights

Magnetically Levitated Centrifugal- vs Continuous-Flow Pump for Advanced HF

March 15, 2018

A magnetically levitated centrifugal-flow pump was superior to a mechanical-bearing axial continuous-flow pump in patients with advanced heart failure.

ACC 2018 Meeting Highlights

Substance Use May Increase Mortality in Younger Patients With MI

March 15, 2018

Cocaine and/or marijuana use was present in 10% of patients with myocardial infarction were ≤50 years old.

ACC 2018 Meeting Highlights

Cardiovascular Outcomes of SGLT-2i vs Other Glucose-Lowering Drugs in T2D

By

Anna Olechowska

March 14, 2018

A recent study evaluated the effects of SGLT-2i and other glucose-lowering drugs on cardiovascular event outcomes in patients with type 2 diabetes from 6 countries in 3 world regions.

Recent algorithms could help clinicians diagnose gout

ACC 2018 Meeting Highlights

Febuxostat May Increase CV Mortality Compared With Allopurinol in Gout

March 14, 2018

Patients with gout and cardiovascular disease who were treated with febuxostat had significantly higher all-cause and cardiovascular mortality compared with those treated with allopurinol.

ACC 2018 Meeting Highlights

Preventing Chemotherapy-Related Cardiotoxicity in Breast Cancer

March 14, 2018

Carvedilol did not prevent reduction in left ventricular ejection fraction in patients with HER2-negative breast cancer, but was linked to lower troponin I levels.